Lexeo Therapeutics Inc (LXEO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LXEO Annual Balance Sheets →
This balance sheet overview for Lexeo Therapeutics Inc spans from Jun 30 2025 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent234.20
Available-for-sale Securities, Debt Securities, Current MA260.21
Cash & Short-term Investments494.00
Prepaid Expense And Other Assets Current6.21
Total Current Assets217.91
Equipment/Property/Plant Net2.01
Long-term investments22.47
Other Assets, Noncurrent12.51
Restricted Cash Noncurrent3.25
Finance Lease Right Of Use Asset1.06
Operating Lease Right Of Use Asset6.19
Total Assets254.90
Liabilities
Accounts Payable, Current AC4.18
Accrued Bonuses, Current3.19
Other Liabilities, Current8.32
Total Current Liabilities15.69
Total Long-term Debt0.00
Other liabilities, Noncurrent4.15
Accrued Liabilities And Other Liabilities Current8.16
Finance Lease Liability Current0.53
Operating Lease Liability Current2.17
Total Liabilities19.84
Stockholders' Equity
Treasury Stock Common Value-0.02
Common Stock Value0.01
Additional Paid In Capital Common Stock661.57
Retained Earnings / Accumulated Deficit-426.20
Accumulated Other Comprehensive Income-0.30
Other Equity-0.30
Common Stockholder's Equity235.06
Total Stockholder's Equity235.06
Liabilities & Stockholder's Equity254.90
4 historic quarters locked

Sign in to unlock the full Lexeo Therapeutics Inc balance sheet history.

About Lexeo Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-345724

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.